P‐BB‐29 | Donor Re‐Entry Following Deferral for False‐Reactive Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Markers
Steven J. Drews(University of Alberta), Sheila F. O’Brien(University of Ottawa), Sajra Užičanin(Canadian Blood Services), Kelly S. MacDonald(Canadian Blood Services), P. Hüppe(Canadian Blood Services), Mark Bigham(Canadian Blood Services)
Cited by 0
Related Papers
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
|Clinical Infectious Diseases|2016|232
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections
|Clinical Microbiology Reviews|2018|190
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015
|The Journal of Infectious Diseases|2017|170
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
|Vaccine|2013|159
Effectiveness of pertussis vaccination and duration of immunity
|Canadian Medical Association Journal|2016|139